InnoCare and ArriVent Announce Clinical Development Collaboration
Companies will collaborate on investigating a novel SHP2 inhibitor in combination with furmonertinib, a highly brain-penetrant, broadly active mutation-selective EGFR…
Pharmaceuticals, Biotechnology and Life Sciences
Companies will collaborate on investigating a novel SHP2 inhibitor in combination with furmonertinib, a highly brain-penetrant, broadly active mutation-selective EGFR…
SAN FRANCISCO and WALTHAM, Mass., July 13, 2023 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc. (Nasdaq: APGE), a biotechnology company advancing…
PRINCETON, N.J., July 13, 2023 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that…
REDWOOD CITY, Calif., July 13, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a…
Offering Includes Exercise in Full of the Underwriters’ Option to Purchase an Additional 3 Million Shares of Common StockSAN CARLOS,…
BOSTON, July 13, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the…
Announced Phase 1b expansion cohorts for NX-2127 in non-Hodgkin’s lymphomas Presented data highlighting the potent cellular activity of both NX-5948…
IRVINE, Calif., July 13, 2023 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company”) is providing additional…
Houston, TX, USA, July 13, 2023 (GLOBE NEWSWIRE) — Invectys, Inc., a clinical-stage immuno-oncology company developing novel therapies for the…
ZTlido® profile has been viewed as a leading prescription lidocaine patch by pain specialists. Based on the independent market research…